Profound Medical Corp. financial data

Symbol
PROF on Nasdaq
Location
2400 Skymark Avenue, Unit 6, Mississauga, Ontario, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.1M shares
Common Stock, Shares, Outstanding 30.1M shares
Entity Public Float 242M USD
Common Stock, Value, Issued 282M USD
Weighted Average Number of Shares Outstanding, Basic 30.1M shares +23%
Weighted Average Number of Shares Outstanding, Diluted 30.1M shares +23%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.21M USD -0.99%
Revenue from Contract with Customer, Excluding Assessed Tax 1.98M USD +1.43%
Cost of Revenue 593K USD -27%
Research and Development Expense 6.1M USD +45%
Operating Income (Loss) -13.8M USD -76.1%
Nonoperating Income (Expense) -1.83M USD -294%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -15.6M USD -127%
Income Tax Expense (Benefit) 64K USD +237%
Net Income (Loss) Attributable to Parent -15.7M USD -127%
Earnings Per Share, Basic 0.52 USD/shares +85.7%
Earnings Per Share, Diluted 0.52 USD/shares +85.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 35.2M USD
Inventory, Net 8.35M USD
Assets, Current 48.8M USD
Deferred Income Tax Assets, Net 101K USD
Property, Plant and Equipment, Net 278K USD
Operating Lease, Right-of-Use Asset 303K USD
Assets 49.7M USD
Accounts Payable, Current 949K USD
Employee-related Liabilities, Current 2M USD
Liabilities, Current 5.72M USD
Contract with Customer, Liability, Noncurrent 74K USD
Deferred Income Tax Liabilities, Net 59K USD
Operating Lease, Liability, Noncurrent 72K USD
Other Liabilities, Noncurrent 77K USD
Liabilities 10.4M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 5.56M USD
Retained Earnings (Accumulated Deficit) -272M USD
Stockholders' Equity Attributable to Parent 39.3M USD +0.94%
Liabilities and Equity 49.7M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.28M USD -82.9%
Net Cash Provided by (Used in) Financing Activities -290K USD -101%
Common Stock, Shares, Issued 30.1M shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 35.2M USD +3.28%
Deferred Tax Assets, Valuation Allowance 53.6M USD +16.5%
Deferred Tax Assets, Gross 53.7M USD +16.7%
Operating Lease, Liability 460K USD
Depreciation 102K USD -44.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13M USD -75.7%
Lessee, Operating Lease, Liability, to be Paid 480K USD
Property, Plant and Equipment, Gross 2.18M USD
Operating Lease, Liability, Current 279K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 206K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 274K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -14K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 20K USD
Deferred Tax Assets, Operating Loss Carryforwards 43M USD +19.3%
Current Income Tax Expense (Benefit) 78K USD +311%
Additional Paid in Capital 23.6M USD
Amortization of Intangible Assets 47K USD -7.84%
Deferred Tax Assets, Net of Valuation Allowance 87K USD
Share-based Payment Arrangement, Expense 1.45M USD +88.9%